Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Crystal Phend MedPage Today Contributing editor at MedPage Today. Personal views. HealthcareEditing	Lower-Dose Extended Anticoagulation Just as Effective for VTE With Active Cancer - 20 days ago Antisense Drug Slashes High Triglycerides - about 1 year ago After Cervical Artery Dissection, Early Anticoagulant Might Be Better - about 1 year ago Tirofiban a Better Option for Ischemic Stroke When Lytics and Thrombectomy Aren't? - about 1 year ago Adjunctive Thrombolysis Doesn't Boost tPA Benefits - about 1 year ago DOAC Cuts Stroke Risk From Subclinical Afib - over 1 year ago Transfusion Thresholds Square Off in Acute Myocardial Infarction - over 1 year ago
2	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Fitusiran Approved for Hemophilia A and B - 20 days ago Eltrombopag Improves Outcomes in Kids With Newly Diagnosed ITP - 4 months ago Novel Monoclonal Antibody Reduces Bleeds in Hemophilia A and B - over 1 year ago Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALL - over 1 year ago First Treatment Approved for Genetic Clotting Disorder - over 1 year ago Emicizumab Can Delay Immunosuppressive Tx in Acquired Hemophilia A - over 1 year ago
3	Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location medical reporting	First Generics for Low-Dose Rivaroxaban Get FDA Approval - about 1 month ago Encouraging DOAC Data for Afib With Various Valvular Heart Diseases - 2 months ago What's With All the UFH Infusions for Acute Pulmonary Embolism? - 3 months ago Stroke Survivors With Afib Could Start DOACs Earlier - 6 months ago A More Selective Enoxaparin Thromboprophylaxis Protocol May Be Safer for New Moms - 10 months ago Most Popular DOAC Holds Its Own Against Edoxaban in Those Age 80 and Up - about 1 year ago Direct Thrombin Inhibitor Shows Benefit for Progressing Stroke - over 1 year ago Nuclear Tracer Shortage; Weighing Post-Ablation OAC; Fix for Biased AI Tools? - over 1 year ago OCEANIC-AF Trial Sunk; Second Renal Denervation Device Approved; Strep-Stroke Link? - over 1 year ago Alteplase Not Harmful in NOAC Users, Even in a More Bleeding-Prone Cohort - over 1 year ago Alleged Stroke Trial Misconduct; Ultrasound Tx for Severe AS; Farxiga's eGFR Drops - over 1 year ago Consequences of Oral Anticoagulant Choice Magnified in the Frail - over 1 year ago FXI Inhibitor Cuts Bleeds in Afib; COAPT Extends to Real World; AI Stroke Triage - over 1 year ago
4	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Andembry treatment approved across Europe - 2 months ago
5	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Novartis’s $925M Anthos Acquisition Brings Back Cardio Drug That Stops Blood Clots - 2 months ago
6	Shelby Bradford, PhD The Scientist Assistant Editor @TheScientistLLC. Opinions my own. scienceediting	Targeting Mosquito Spit Could Stop Parasites in Their Tracks - 4 months ago
7	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	Novel BTK Inhibitor Succeeds in Heavily Pretreated Immune Thrombocytopenia - 4 months ago GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots - 4 months ago
8	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	Sanofi advances a drug for a rare, platelet-destroying disease - 4 months ago
9	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	Sanofi advances a drug for a rare, platelet-destroying disease - 4 months ago
10	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	GLP1 Agonists and Dietary Fiber May Reduce VTE Risk and Improve GVHD Outcomes - 4 months ago Abelacimab Demonstrates Significant Reduction in Bleeding vs Rivaroxaban in Patients With Atrial Fibrillation - over 1 year ago

Journalists covering antithrombin